Alkermes plc (ALKS)

Healthcare · Drug Manufacturers Specialty Generic · NASDAQ

Alkermes plc (ALKS) is a Healthcare company in the Drug Manufacturers Specialty Generic industry. It has a market capitalization of $7.26B, a trailing price-to-earnings ratio of 19.6 and a free-cash-flow yield of 6.6%. Over the most recent reported fiscal year, revenue declined 5.2% and free cash flow per share grew 18.7%.

Market cap	$7.26B
Trailing P/E	19.6
FCF yield	6.6%
Revenue growth (YoY)	-5.2%
EPS growth (YoY)	-27.8%
FCF/share growth (YoY)	+18.7%
Exchange	NASDAQ
Sector	Healthcare
Industry	Drug Manufacturers Specialty Generic

Explore live ALKS data on Nama Insights →

Recent Congressional trades

Alkermes plc trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member	Chamber	Trade	Amount	Disclosed
Gilbert Cisneros	House	Buy	$15,001 - $50,000	Sep 4, 2026